UNSPSC 51112601: Carmustine

This classification denotes a nitrosourea compound and dna adduct forming agent with the molecular formula C5H9Cl2N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U68WG3173Y, chemically known as 1,3-bis(beta-chloroethyl)-1-nitrosourea but more generally known as carmustine, which bears US NIH Compound Identifier 2578. European Medicines Agency schedules Carmustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06132MIG.

UNSPSC 51112601 Carmustine is a Commodity code representing a chemotherapy agent that state and local governments procure primarily through health departments, correctional facilities, and public hospital systems for oncology treatment programs. The code covers carmustine (BCNU), a nitrosourea-class alkylating agent used in cancer chemotherapy protocols, typically acquired as a pharmaceutical supply through bulk purchasing or standing orders rather than as a one-time project deliverable. Issuing bodies include state health departments, county public health agencies, municipal hospitals, and state corrections departments that maintain inpatient oncology or specialized treatment capacity.

The source provides no recent state and local contract opportunities specifically tagged to UNSPSC 51112601. Without posted solicitations, RFPs, RFQs, or ITBs naming this code in the <most-recent-state-local-contract-opportunities> block, geographic concentration and representative activity cannot be determined from this source. Firms pursuing state and local pharmaceutical procurement should monitor health-system RFQs and state health department standing-order notices, which typically post on individual agency procurement portals rather than centralized platforms; carmustine is acquired through these channels but does not appear in readily available recent state and local solicitation data.